Currently out of the existing stock ratings of Lu Li, 5 are a BUY (17.86%), 23 are a HOLD (82.14%).
Analyst Lu Li, currently employed at UBS, has had 85.95% of price targets met with an average potential upside of 28.73%, reached in 72 days on average.
Lu Li has documented 56 price targets and ratings displayed on 5 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on QDEL, at 07-May-2026.
Analyst best performing recommendations are on QDEL.
The best stock recommendation documented was for QDEL on 4/10/2026. The price target of $17 was fulfilled within 4 days with a profit of $3.15 (22.74%), with a performance score of 56.86.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 13-Mar-2023
$25
$0.34 (1.38%)
$19
6 days ago
(10-Nov-2026)
Hold Since 05-Aug-2025
$30
1 years 3 months 11 days ago
(05-Aug-2025)
1/1 (100%)
$9.22 (44.37%)
108
Buy Since 18-Nov-2022
$25
$45
1 years 6 months 11 days ago
(05-May-2025)
1/2 (50%)
$5.44 (27.81%)
186
Hold Since 07-Dec-2023
$27
$25
2 years 3 months 11 days ago
(05-Aug-2024)
2/6 (33.33%)
$3.33 (14.07%)
309
Buy Since 20-Aug-2020
$125
$141
4 years 9 months 22 days ago
(25-Jan-2022)
4/8 (50%)
$61.5 (96.85%)
70
What Year was the first public recommendation made by Lu Li?